2020 American Transplant Congress
Late De Novo Donor Specific Antibodies in Steroid Free Immunosuppression and Delayed Graft Function
Temple University School of Medicine, Philadelphia, PA
*Purpose: Donor Specific Antibodies (DSA) have been implicated in acute and chronic antibody-mediated rejection. Once developed, they tend to be persistent and lead to transplant…2020 American Transplant Congress
Hepaticojejunostomy versus Duct to Duct Anastomosis in Liver Transplantation: An Old Question Revisited
Henry Ford Hospital, Detroit, MI
*Purpose: Two surgical techniques are currently used for biliary reconstruction and each has its advantages/disadvantages. However, it is unclear if the used technique can impact…2020 American Transplant Congress
The Association of Body Weight Gain/Change and Hepatocellular Carcinoma Recurrence after Liver Transplant
*Purpose: Functional recovery in liver transplant recipients is commonly confounded by weight changes relating to various aspects of liver disease such as cachexia, ascites and…2020 American Transplant Congress
Living Donor versus Deceased Donor Liver Transplantation in USA: Where Do We Stand, Where to Go
1Henry Ford Hospital, Detroit, MI, 2University of Chicago Medical Center, Chicago, IL
*Purpose: LDLT represents a very small percentage of all liver transplants done in the United States, despite the shortage of deceased donor organs. The aim…2020 American Transplant Congress
The Centennial Allograft – Can an Organ Function for Over 100 Years in 2 Different Individuals?
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: We investigated the occurrence of deceased-donor liver (DDOLT), deceased-donor renal (DDRT), and living-donor renal allografts (LDRT) that have achieved or come close to 100…2020 American Transplant Congress
Comparison of Prophylaxis Strategies for CMV Infection in Liver Transplant Recipients
The Ohio State Wexner Medical Center, Columbus, OH
*Purpose: The best strategy to prevent cytomegalovirus (CMV) following liver transplantation is not defined for intermediate risk recipients (recipient seropositive (R+) regardless of donor status).…2020 American Transplant Congress
Incidence of Cytomegalovirus Infection in Deceased Donor Kidney Transplantation from Hepatitis-C Antibody Positive Donors to Hepatitis-C Antibody Negative Recipients: A National Registry Analysis
*Purpose: Deceased donor kidney transplantation (KT) from hepatitis C (HCV) infected donors into HCV uninfected recipients (HCV D+/R-) will be the standard of care in…2020 American Transplant Congress
The Accuracy of the ICD-10 Diagnostic Codes for Kidney Transplant Rejection and Failure
*Purpose: Clinical research requires that diagnostic codes captured from routinely collected health administrative data accurately identify individuals with a disease. In this study, we examined…2020 American Transplant Congress
Relationship between Tacrolimus Intrapatient Variability and Medication Adherence in Kidney Transplant Recipients
The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: Intrapatient variability (IPV) has been established as a risk factor for poor post-transplant outcomes. IPV is frequently proposed to be related to nonadherence but…2020 American Transplant Congress
Acute Respiratory Distress Syndrome in a Simultaneous Kidney/Pancreas Transplant Recipient after “Dabbing” with Marijuana Rosin: A Case Report
*Purpose: Acute Respiratory Distress is a high-risk complication of lung inflammation that has been linked to multiple exogenous agents.*Methods: We present the case of a…
- « Previous Page
- 1
- …
- 215
- 216
- 217
- 218
- 219
- …
- 223
- Next Page »